Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8748601
Selective serine/threonine kinase inhibitors
granted -
US 8748176
Generation of choroid plexus epithelial cells from human embryonic stem cells
granted -
US 8741306
Kidney specific tumor vaccine directed against kidney tumor antigen G-250
granted -
US 8741589
Monitoring two dimensions of diabetes pathogenesis
granted -
US 8735057
Fluorescence detection of poison oak oil
granted -
US 8734799
Unconjugated anti-TfR antibodies and compositions thereof for the treatment of cancer
granted -
US 8729039
Use of inhibitory oligonucleotides to treat autoimmune disease
granted -
US 8729088
Toll-like receptor modulators and treatment of diseases
granted -
US 8728458
Combination anti-HIV vectors, targeting vectors, and methods of use
granted -
US 8728757
Methods of modulating cold sensory perception via a cold- and menthol-sensitive receptor (CMR1)
granted -
US 8722896
Prokineticin receptor antagonists and uses thereof
granted -
US 8716246
Azuvirin peptides
granted -
US 8715653
Modulation of Rhamm (CD168) for selective adipose tissue development
granted -
US 8709452
Synthetic bone grafts
granted -
US 8710030
Phosphonate compounds
granted -
US 8703920
Fully human antibodies against N-cadherin
granted -
US 8703751
Androstenediol as an indicator for assessing estrogenicity
granted -
US 8697836
Composition and method for inducing and enhancing a telomerase reverse transcriptase-reactive cytotoxic T lymphocyte response
granted -
US 8697709
Fused ring heteroaryl kinase inhibitors
granted -
US 8697348
Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571
granted -
US 8697079
IgE antibodies for the treatment of cancer
granted -
US 8697082
Prevention and treatment of synucleinopathic and amyloidogenic disease
granted -
US 8691204
Synthetic diblock copolypeptide hydrogels for use in the central nervous system
granted -
US 8691768
Methods of determining delta opioid receptor subtypes
granted